Unknown

Dataset Information

0

Pan-HSV-2 IgG antibody in vaccinated mice and guinea pigs correlates with protection against herpes simplex virus 2.


ABSTRACT: We lack a correlate of immunity to herpes simplex virus 2 (HSV-2) that may be used to differentiate whether a HSV-2 vaccine elicits robust or anemic protection against genital herpes. This gap in knowledge is often attributed to a failure to measure the correct component of the adaptive immune response to HSV-2. However, efforts to identify a correlate of immunity have focused on subunit vaccines that contain less than 3% of HSV-2's 40,000-amino-acid proteome. We were interested to determine if a correlate of immunity might be more readily identified if 1. animals were immunized with a polyvalent immunogen such as a live virus and/or 2. the magnitude of the vaccine-induced immune response was gauged in terms of the IgG antibody response to all of HSV-2's antigens (pan-HSV-2 IgG). Pre-challenge pan-HSV-2 IgG levels and protection against HSV-2 were compared in mice and/or guinea pigs immunized with a gD-2 subunit vaccine, wild-type HSV-2, or one of several attenuated HSV-2 ICP0 (-) viruses (0?254, 0?810, 0?RING, or 0?NLS). These six HSV-2 immunogens elicited a wide range of pan-HSV-2 IgG levels spanning an ?500-fold range. For 5 of the 6 immunogens tested, pre-challenge levels of pan-HSV-2 IgG quantitatively correlated with reductions in HSV-2 challenge virus shedding and increased survival frequency following HSV-2 challenge. Collectively, the results suggest that pan-HSV-2 IgG levels may provide a simple and useful screening tool for evaluating the potential of a HSV-2 vaccine candidate to elicit protection against HSV-2 genital herpes.

SUBMITTER: Halford WP 

PROVIDER: S-EPMC3675040 | biostudies-literature | 2013

REPOSITORIES: biostudies-literature

altmetric image

Publications

Pan-HSV-2 IgG antibody in vaccinated mice and guinea pigs correlates with protection against herpes simplex virus 2.

Halford William P WP   Geltz Joshua J   Gershburg Edward E  

PloS one 20130606 6


We lack a correlate of immunity to herpes simplex virus 2 (HSV-2) that may be used to differentiate whether a HSV-2 vaccine elicits robust or anemic protection against genital herpes. This gap in knowledge is often attributed to a failure to measure the correct component of the adaptive immune response to HSV-2. However, efforts to identify a correlate of immunity have focused on subunit vaccines that contain less than 3% of HSV-2's 40,000-amino-acid proteome. We were interested to determine if  ...[more]

Similar Datasets

| S-EPMC5125880 | biostudies-literature
| S-EPMC6485947 | biostudies-literature
| S-EPMC8802144 | biostudies-literature
| S-EPMC4122653 | biostudies-literature
| S-EPMC3637765 | biostudies-literature
| S-EPMC7472045 | biostudies-literature
| S-EPMC192055 | biostudies-other
| S-EPMC3935479 | biostudies-literature
| S-EPMC6289718 | biostudies-literature
| S-EPMC7004361 | biostudies-literature